Best Bladder cancer Doctors Worldwide — TOP 147

Dr. Bülent Karagöz brings 33 years of experience of oncology expertise, specializing in advanced bladder cancer treatments at Anadolu Medical Center.

• Subspecializes in tumor biology and cancer immunotherapy
• Professor at Istanbul Okan University Faculty of Medicine
• Author of 40+ publications in cancer research
• Member of the Turkish Medical Oncology Association
• Provides consultations in English and Turkish

Prof. Ilker Tinay specializes in bladder cancer surgery and reconstruction at Anadolu Medical Center – a Johns Hopkins-affiliated hospital.

• Head of the Oncourology Department with leadership roles in uro-oncology associations
• Expert in minimally invasive surgery and neo-bladder reconstruction techniques
• Board member of the International Bladder Cancer Network
• Member of the European Association of Urology and American College of Surgeons

Dr. Barak Rosenzweig directs the Urological Oncology Service at Sheba Medical Center in Israel. He is a surgeon who has been listed among Israel’s Best Doctors by Forbes. Dr. Rosenzweig specializes in treating tumors of the prostate, kidney, bladder, and testis. He focuses on robotic and minimally invasive cancer surgery to preserve organ function.

• Completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center.
• Performs robotic radical prostatectomy and kidney-sparing partial nephrectomy.
• Clinical Senior Lecturer at Tel Aviv University with over 200 scientific publications.
• Uses MRI-guided fusion biopsy for high-precision prostate cancer detection.

Dr. Solak completed his fellowship at Hacettepe University Cancer Institute, specializing in complex oncology cases.

• Deals with various cancers including bladder, breast, and lung
• Trained at The University of Texas MD Anderson Cancer Center
• Specialized in oncology at Istanbul Sisli Etfal Training and Research Hospital
• Works at Hisar Hospital Intercontinental

Dr. Eda Tanrikulu specializes in medical oncology and chemotherapy, focusing particularly on bladder cancer treatment at Anadolu Medical Center.

• Trained at Ankara University and Istanbul University – top medical schools in Turkey
• Ranked 3rd in Turkey on the minor specialty exam
• Active in international clinical studies for medical oncology
• Former head of medical oncology at Haydarpaşa Numune Training and Research Hospital

Dr. Sarid leads the Oncology Department at Sourasky Medical Center, specializing in bladder cancer with innovative treatments like immunotherapy and targeted therapy.

• Senior oncologist since 1997, department chief since 2009
• Fellowship in cancer urology at Oxford University
• Principal investigator in clinical trials for new cancer therapies
• Published 30+ articles on cancer treatment
• Member of ESMO, ASCO, and Israeli oncology societies

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Prof. Zielinski leads Austria's largest oncology department and pioneered personalized cancer therapies at Vienna Cancer Center.

• 44 years of experience specializing in medical oncology and immunotherapy
• Founded Comprehensive Cancer Center Vienna (CCC)
• Former President of Central European Cooperative Oncology Group
• Published extensively in leading oncology journals
• Medical Director at Wiener Privatklinik's International Oncology Center

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center with 41 years of experience in orthopedic oncology.

• Associate Professor of Oncology at Sackler Faculty of Medicine
• Fellowship in sarcoma treatment at Institut Gustave Roussy, Paris
• Active member of ESMO Sarcoma Faculty and ASCO
• Published extensive research on bone and soft tissue cancers

Dr. Sudchumphae combines integrative oncology with conventional treatments, offering a holistic approach to bladder cancer care at Panacee Hospital Rama2.

• Certified in integrative oncology by the American Institute of Integrative Oncology
• Trained in clinical nutrition and functional medicine
• Holds multiple advanced degrees in medical and health sciences

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Specializes in natural and integrative approaches to cancer care, including mistletoe therapy and high-dose vitamin C treatments.

• Expert in treating precancerous conditions and early-stage cancers
• Skilled in managing chemotherapy and radiation therapy side effects
• Attended international conferences with German oncology experts
• Provides comprehensive pain management for cancer patients

Dr. Enrique Grande is a renowned medical oncologist at Hospital Ruber Internacional in Madrid. He has authored over 300 peer-reviewed scientific publications. Dr. Grande focuses on genitourinary and rare endocrine tumors. He serves as a pioneer in precision oncology and molecular profiling.

• Directs the Medical Oncology Department at QuirónSalud.
• Treats complex cases of bladder, kidney, and prostate cancers.
• Contributes to international guidelines for ESMO and ASCO.
• Leads global clinical trials to set new cancer care standards.

Specializes in bladder cancer treatment with extensive experience in minimally invasive urology techniques at German Oncology Centre, Limassol.

• Fellow of the European Board of Urology (FEBU)
• Expert in andrology and reconstructive surgery
• Active in clinical research for urological conditions
• Honorary Senior Lecturer at St Andrews University

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Prof. Sezer Sağlam specializes in bladder cancer treatment at Gayrettepe Florence Nightingale Hospital, bringing decades of focused expertise.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University Medical Faculty
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Extensive experience in gastrointestinal oncology

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Professor Doctor Sefik Igdem specializes in Radiation Oncology with advanced technologies like Truebeam Stx and Halcyons.

• Over 30 years of experience of experience in radiation oncology
• Specializes in head and neck cancers alongside bladder cancer
• Professor at T.R. Demiroğlu Bilim University
• Trained at Istanbul University – one of Turkey's top medical schools